Loading clinical trials...
Loading clinical trials...
Determination of Plasma and Intracellular Levels of Nucleoside Reverse Transcriptase Inhibitors (NRTI) and of Nucleotide Analog Tenofovir Disoproxil Fumarate (TDF) in Patients Treated With Abacavir and/or Lamivudine Given With or Without TDF.
Conditions
Interventions
Patients in treatment with 3TC + TDF + LPV/rtv, stop tenofovir during 4 weeks
Patients in treatment with ABV + TDF + LPV/rtv, stop tenofovir during 4 weeks
+1 more
Locations
1
Spain
Hospital Universitari Germans Trias i Pujol
Badalona, Barcelona, Spain
Start Date
January 1, 2005
Primary Completion Date
September 1, 2005
Completion Date
September 1, 2005
Last Updated
September 8, 2008
NCT04929028
NCT01875588
NCT07071623
NCT03087253
NCT07199335
NCT05419024
Lead Sponsor
Germans Trias i Pujol Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions